Reinfection, recontamination and revaccination for SARS-CoV-2  

作　　者：Tamás Kullmann András Drozgyik 

机构地区：[1]Department of Medical Emergencies,Petz Aladár Hospital,Győr 9024,Hungary [2]Department of Surgery,Petz Aladár Hospital,Győr 9024,Hungary

出　　处：《World Journal of Methodology》2022年第4期258-263,共6页世界方法学杂志

摘　　要：The reports on coronavirus disease 2019(COVID-19)describe the pandemic in waves.Similar to the ocean’s waves,the frequency and amplitude of the number of new cases and the number of deaths were globally quite regular;nevertheless,they showed important regional irregularities and the direction of spread has been generally rather unpredictable for COVID-19.One of the major reasons for the repeated outbreaks is the mutating capacity of the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)that allows the virus to infect persons who have natural immunity or have been vaccinated.Vaccination began in vast campaigns from the second year of the pandemic that was supposed to decrease the magnitude of the waves.Although it reduced the complications,the expected attenuation of the disease expansion has not yet been met.This paper provides a short overview of the most recent data on the rate of reinfection in vaccinated and non-vaccinated individuals.It points out that testing positive for a second time for SARS-CoV-2 does not necessarily mean a reinfection;it can also be interpreted as recontamination.The symptom free outcome as well as the rapid reconversion of the polymerase chain reaction test may help to determine the difference between reinfection and recontamination.Awareness of this phenomenon may be valuable in times of human resource difficulties.The available evidence may suggest that the protective value of a prior infection could be better considered for vaccine distribution in the future.

关 键 词：SARS-CoV-2 COVID-19 Polymerase Chain Reaction IMMUNISATION Contamination VACCINATION 

分 类 号：R37[医药卫生—病原生物学]